Welcome to PsychU!

Virtual Event – Addressing Unresolved Symptoms of Major Depressive Disorder

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Virtual Event – Addressing Unresolved Symptoms of Major Depressive Disorder

Objectives:

  • Understand why many patients with MDD continue to experience unresolved symptoms following first-line treatment
  • Understand why the optimal outcome for a patient with MDD involves full symptom recovery
  • Discuss different strategies commonly used to address inadequate response to treatment
  • Learn how adjunctive atypical antipsychotics (AAPs) fit into the treatment paradigm for patients with MDD

Featuring

Chet-Robachinski

Chet Robachinski, MD

Psychiatric Director, Bailey-Boushay House, Seattle, WA; Founding Partner, Associates in Behavioral Health

Simon-Kim

Simon Kim, PharmD

Medical Science Liaison

Chet Robachinski, MD is a speaker for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Simon Kim, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Log in to register

Related Resources

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Join PsychU Today to receive a wide array of tools and benefits

  • Join our multidisciplinary community that is improving mental health care… together
  • Quickly learn more about the topics you're interested in
  • Access an award-winning library of on-demand mental health resources
  • Gain key insights from industry expert & thought leaders